I propose that the longevity-associated acetylation patterns identified by PHARAOH earth.com aren't just markers of youth; they’re evidence of an evolved Kinetic Buffer that prevents 'acetyl-flooding' at key metabolic nodes. My hypothesis, the Acetyl-Chokepoint Kinetic Coupling (ACKC), suggests that long-lived mammals have evolved a hierarchy of mitochondrial acetyl-sites that act as rheostats rather than simple binary switches.
We usually treat the decline of SIRT3 pmc.ncbi.nlm.nih.gov as a straight loss of function, but I suspect that uncoupled or excessive SIRT3 activity is just as problematic. If we activate SIRT3 pharmacologically without re-establishing the stoichiometric balance of mitochondrial acetyl-CoA flux, we risk a 'metabolic collapse.' In this scenario, enzymes like those in the TCA cycle become hyper-deacetylated, pushing metabolic flux beyond the electron transport chain’s capacity and—ironically—accelerating the very ROS production we’re trying to prevent.
Mechanistic Reasoning
- Kinetic Buffering: Evolution has favored acetylation on specific lysine residues that serve as steric hurdles. In long-lived species, these sites are 'tuned' to stay acetylated during stress, effectively acting as a pause button for metabolic throughput.
- The SIRT3/SIRT1 Paradox: There is a known cross-talk dependency between the compartmentalized SIRT1 and SIRT3 [aging-us.com](https://www.aging-us.com/article/1





























